Global Mobile Cardiac Telemetry Market is expected to foresee significant growth. APAC to lead the growth!
- Vikas Kumar
- September 11, 2021
- MEDICAL DEVICES
- 0 Comments
Mobile cardiac telemetry (MCT) is a relatively new technology, first approved in 2002 by the US Food and Drug Administration (FDA), which provides continuous real-time outpatient electrocardiographic monitoring for extended periods of time. MCT allows detection of both symptomatic and asymptomatic arrhythmias and has been proven to provide superior diagnostic capability for patients with palpitations, syncope, and pre-syncope. It also allows accurate monitoring of a patient’s rhythm during outpatient drug titration, as well as detection of both symptomatic and asymptomatic atrial fibrillation after cardiac ablation. The rising investment by pharmaceutical gaints is one of the major factor boosting the growth of the market. For instance, in May 2021, VitalConnect launched its VitalPatch RTM mobile cardiac telemetry (MCT) solution.
The Mobile Cardiac Telemetry Market is expected to grow at a steady rate of around 12.2% during the forecast period (2022-2028) owing surge in the prevalence of cardiovascular diseases. Cardiovascular disease (CVD) is the leading cause of death worldwide. According to the World Heart Federation, it accounts for 30% of all deaths every year an estimated 17.3 million. The demand for cardiac monitoring products for diagnostics is driven by the increasing prevalence of CVD due to urbanization with greater exposure to pollution and stress, lifestyle changes such as consumption of high-calorie foods and less exercise, and genetic issues such as long QT syndrome and catecholaminergic polymorphic ventricular tachycardia.
For a detailed analysis of the Global Mobile Cardiac Telemetry Market browse through – https://univdatos.com/report/mobile-cardiac-telemetry-devices-market/
Based on technology, the market is bifurcated into lead-based MCT device and patch-based MCT device. The lead based MCT device held a dominant share of the market in 2021 owing to several advantages in terms of efficacy, light weight, cost-efficiency. Moreover, wide range of product availability is also driving the share of the segment.
Based on end-users, the market is segmented into hospitals, ambulatory surgical centers, and home setting. The ambulatory surgical centers are expected to hold a significant share of the market due to the increased demand for out-patient services. Apart from this, the cost-effectiveness and shorter day duration is other factors propelling the growth of this segment during the forecast period. Moreover, the rise in the number of ambulatory surgical centers (ASC) is also driving market growth. For instance, According to the statistics by the Centers for Medicare & Medicaid Services (CMS), in 2020, the number of Medicare-certified ASCs in the U.S. was 5,935 compared to 5,105 in 2019.
Request for a sample of the report browse through – https://univdatos.com/get-a-free-sample-form-php/?product_id=9874
For a better understanding of the market adoption of the neoantigen cancer vaccine, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, Rest of North America), Europe (Germany, U.K., France, Sweden, Netherlands, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World (Brazil, South Africa, and Other ROW). APAC is anticipated to grow at a substantial CAGR during the forecast period owing to the surge in the incidence of cardiovascular diseases and the growing geriatric population. For instance, according to World Health Organisation (WHO), smoking causes around 1 million cardiovascular deaths in Asia-Pacific region each year. Moreover, Japan is the country with the highest life expectancy, this will directly influence the growth of wearable medical device market as rise in geriatric population leads to the escalation of age-related disorders.
Some of the major players operating in the market include Asahi Kasei Corp., BioTelemetry Inc., Biotricity, Comarch, Hill-Rom Holdings Inc, Infobionic, Koninklijke Philips N.V., Medicalgorithmics, Medicomp, and Preventice Solutions.
Global Mobile Cardiac Telemetry Market Segmentation
Market Insight, by Technology
· Lead-Based MCT Device
· Patch-Based MCT Device
Market Insight, by End-Users
· Hospitals
· Ambulatory Surgical Centers
· Home Setting
Market Insight, by Region
· North America
o U.S.
o Canada
o Rest of North America
· Europe
o Germany
o United Kingdom
o France
o Italy
o Sweden
o Netherlands
o Rest of Europe
· Asia-Pacific
o China
o Japan
o India
o Rest of Asia-Pacific
· Rest of the World
o Brazil
o South Africa
o Other ROW
Top Company Profiles
· Asahi Kasei Corporation
· BioTelemetry Inc.
· Biotricity
· Comarch
· Hill-Rom Holdings Inc
· Infobionic
· Koninklijke Philips N.V.
· Medicalgorithmics
· Medicomp
· Preventice Solutions
Related Posts
